Page 4 - Diagnostics

Theranos COO Ramesh Balwani found guilty of multimillion-dollar fraud in US

The federal jury in San Jose on Thursday found Pakistan-born Balwani, 57, guilty of two counts of conspiracy and ten counts of wire fraud through a multimillion-dollar scheme

Price rationalisation, consolidation likely in Indian diagnostic space

Competitive pricing, however, is here to stay, feel analysts and some industry insiders

Cipla to acquire 21% stake in diagnostic company Achira Labs for Rs 25 cr

The company has signed definitive agreements with Achira Labs for the purpose, Cipla said in a regulatory filing

Lots of interest in Metropolis, but we want a strategic fit: MD Ameera Shah

In a Q&A, the promoter and MD of the company talks about how the dynamics are changing in the diagnostics sector post Covid, and outlines her strategy for Metropolis 3.0

Covid-19: Analysts dump diagnostic firms for multiplexes on solid outlook

Experts believe the current news cycle may keep the stock prices of related players volatile in the near term, but any fundamental or direct impact, in the long run, remains improbable.

Why are analysts dumping diagnostics sector for multiplexes?

Soon after the news of rising Covid-cases in parts of India, diagnostic and multiplex stocks moved in opposite directions on Monday. Find out analysts' views on the two sectors and if should you worry

Near-term outlook prescription for diagnostic firms looks fragile

Competitive pressures, high valuations limit upsides for listed lab chains

Neuberg Diagnostics to double its labs in next two years: Chairman

Diagnostics chain Neuberg Diagnostics has plans to double its laboratories and touchpoints from present 150 labs and 1,000 touchpoints present across globe in next two years, company official said

Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit

The kit is validated by the Indian Council of Medical Research (ICMR) and much more advanced than other RT PCR tests, the drug firm said

Redcliffe Lifetech raises $61 mn for expansion; LeapFrog Investments leads

The funding to Redcliffe Lifetech would help the diagnostic platforms to expand access to affordable, high-quality diagnostic tests across India, especially in tier 2, 3, and 4 cities

SpiceJet's Ajay Singh starts healthcare and diagnostics platform Flebo

Flebo, a one-stop destination that allows booking of healthcare and diagnostic tests from any lab of the customer's choice, has launched in Delhi, Gurugram and Noida

Metropolis Healthcare to set up 1,800 collection centres in three years

The company is planning to add around 40 more Hitech centres during the current financial year

Manipal HealthMap acquires Hyderabad-based Medcis PathLabs in all cash-deal

Through this acquisition, Manipal HealthMap will have access to additional 19 laboratories, including one NABL accredited central laboratory in Hyderabad.

Neuberg Diagnostics becomes official diagnostic partner for CSK

This is the second year the IPL has partnered with Neuberg Diagnostics as its diagnostic partner and has started conducting COVID-19 tests for IPL team members

Tech firm MFine helps people monitor blood pressure, glucose on smartphones

MFine has democratised health care at home by bringing these solutions on to devices that are more ubiquitous and affordable than wearables

Health technology platform Tata 1mg steps up diagnostics play

Since Tata 1mg is focused on online diagnostics and home collection of samples, it has third-party partners for radiology tests

Karakoram sells shares of Vijaya Diagnostic worth over Rs 332 crore

Karakoram Ltd on Monday offloaded shares of Vijaya Diagnostic Centre Ltd worth over Rs 332 crore through an open market transaction.

Skye Air begins drone delivery trials for diagnostic sample collection

On the first day of the trials at Noida, six flights were operated for sample collection, the drone delivery services provider said in a statement

Metropolis Healthcare net profit dips 30% to Rs 41 cr in December quarter

Metropolis Healthcare on Friday said its net profit declined 29.69 per cent to Rs 41.2 crore for the third quarter ended December 31, 2021. The diagnostics chain had reported a net profit of Rs 58.6 core in the same period of previous fiscal. Revenues, however, increased to Rs 293.1 crore in the period under review as against Rs 274.7 crore in the same period of 2020-21 fiscal, Metropolis Healthcare said in a statement. "We have been able to grow our non-COVID revenue despite a sharp drop in volumes from a government contract. We have made increased investments in digital and marketing, manpower & customer experience initiatives in order to strengthen our brand. This has impacted margins which we believe is a short-term phenomenon," Metropolis Healthcare Promoter and Managing Director Ameera Shah noted. The company has been able to successfully complete the acquisition of Hitech Diagnostics during the third quarter which will enable it to scale up business, improve the B2C revenue

Thyrocare Technologies names Rahul Guha as MD & CEO

A graduate of IIM-B, Guha has spent almost 17 years at Boston Consulting Group (BCG), where he has led the healthcare and life sciences practice